SINGAPORE -- Survivors who lived through the SARS crisis in Singapore nearly two decades ago may yield hope for the development of a super vaccine to combat potent COVID-19 variants and even other coronaviruses, new research shows.
COVID vaccines
Singapore SARS survivors yield hope for COVID super vaccine
Pfizer recipients found with 'highly potent' antibodies to respiratory viruses
A vial of the Pfizer vaccine in Singapore: A study found former SARS patients inoculated with the shot showed antibodies "capable of neutralizing not only all known SARS-CoV-2 variants of concern but also other animal coronaviruses." © Reuters
Read Next
Latest on COVID vaccines
